Hormones released after a brain injury contribute to movement problems on the left and right sides of the body, scientists from Uppsala University and elsewhere
People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer’s disease, when compared
A recent study has shown that all participants achieve normalization of CNS injury biomarkers, regardless of previous disease severity or persistent neurological symptoms, indicating that
Researchers have developed a powerful miniature brain platform to study the mechanistic causes of Alzheimer’s disease and to test dementia drugs in development.
A study provides new data on potential aetiological mechanisms that are linked with dementia caused by diseases, such as Alzheimer’s and vascular dementia.